Clinical trial
Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma
NCT00004874 · University of Nebraska, Other · Terminated
Key facts
| NCT number | NCT00004874 |
|---|---|
| Title | Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma |
| Official title | Expanded Access Study of Iodine-131 Anti-B1 Antibody for Relapsed/Refractory Low-Grade and Transformed Low-Grade Non-Hodgkin's Lymphoma |
| Lead sponsor | University of Nebraska, Other |
| Collaborators | National Cancer Institute (NCI) NIH Coulter Pharmaceutical, Inc. Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Radiation |
| Interventions | tositumomab and iodine I 131 tositumomab |
| Enrollment | 31 |
| Start date | Nov 1, 1998 |
| Primary completion | Apr 1, 2002 |
| Completion | Nov 1, 2012 |
| First posted | Dec 16, 2003 |
| Last update posted | Jan 17, 2018 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: